H

Hangzhou AGS MedTech Co Ltd
SSE:688581

Watchlist Manager
Hangzhou AGS MedTech Co Ltd
SSE:688581
Watchlist
Price: 60.47 CNY -5.07% Market Closed
Market Cap: 4.9B CNY
Have any thoughts about
Hangzhou AGS MedTech Co Ltd?
Write Note

Hangzhou AGS MedTech Co Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hangzhou AGS MedTech Co Ltd
Pre-Tax Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
H
Hangzhou AGS MedTech Co Ltd
SSE:688581
Pre-Tax Income
ÂĄ251.7m
CAGR 3-Years
70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Pre-Tax Income
ÂĄ596.4m
CAGR 3-Years
70%
CAGR 5-Years
91%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Pre-Tax Income
ÂĄ2B
CAGR 3-Years
5%
CAGR 5-Years
17%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Pre-Tax Income
ÂĄ14.2B
CAGR 3-Years
19%
CAGR 5-Years
24%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Pre-Tax Income
ÂĄ852.2m
CAGR 3-Years
-12%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Pre-Tax Income
ÂĄ2.1B
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hangzhou AGS MedTech Co Ltd
Glance View

Market Cap
4.9B CNY
Industry
Health Care

Hangzhou AGS MedTech Co., Ltd. engages in the research and development, manufacture, and sale of equipment in minimally invasive diagnosis and treat. The company is headquartered in Hangzhou, Zhejiang and currently employs 501 full-time employees. The company went IPO on 2023-05-19. The firm's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.

Intrinsic Value
86.8 CNY
Undervaluation 30%
Intrinsic Value
Price
H

See Also

What is Hangzhou AGS MedTech Co Ltd's Pre-Tax Income?
Pre-Tax Income
251.7m CNY

Based on the financial report for Dec 31, 2023, Hangzhou AGS MedTech Co Ltd's Pre-Tax Income amounts to 251.7m CNY.

What is Hangzhou AGS MedTech Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 3Y
70%

Over the last year, the Pre-Tax Income growth was 52%. The average annual Pre-Tax Income growth rates for Hangzhou AGS MedTech Co Ltd have been 70% over the past three years .

Back to Top